Hertrust 150mg Injection contains Trastuzumab, a treatment for HER2-positive breast cancer. In these cancers, HER2 proteins on the cells signal rapid tumor growth. Hertrust is also used for metastatic gastric cancer with elevated HER2 protein levels.
HER2-positive breast cancers are generally more aggressive. This targeted therapy works by specifically attacking the proteins driving cancer's growth, development, and spread. You must use effective birth control during treatment and for at least 7 months after your last dose.
Hertrust 150mg Injection is not advised for individuals under 18, or those with severe breathing issues or requiring oxygen therapy. Inform your doctor if you have heart problems, experience breathlessness, or have undergone prior cancer treatments. Before starting Hertrust, disclose all medications you are taking, including supplements and herbal remedies.
Option 2: Emphasizing Patient Understanding
Hertrust 150mg Injection is a medication with Trastuzumab as its active ingredient, used to treat HER2-positive breast cancer. In this type of cancer, an abundance of HER2 proteins on the cancer cells signals them to grow and develop tumors rapidly. Hertrust is also an option for metastatic gastric cancer when HER2 protein levels are high.
HER2-positive breast cancers are known for being highly aggressive. The targeted approach of Hertrust works by precisely targeting the proteins responsible for the cancer's growth, progression, and spread. It is crucial to use effective birth control throughout your treatment and for a period of at least 7 months after your final injection.
Hertrust 150mg Injection is not recommended for patients under 18 years of age, or for those who have severe breathing difficulties or are on oxygen treatment. It is important to inform your physician about any heart conditions, breathlessness, or if you have a history of other cancer treatments. Before beginning treatment with Hertrust, ensure your physician is aware of all medications you are taking, including any supplements or herbal medicines.
Option 3: More Formal and Clinical
Hertrust 150mg Injection, a formulation of Trastuzumab, is indicated for the management of HER2-positive breast cancer. In HER2-positive patients, an overabundance of HER2 proteins on breast cancer cells drives rapid tumor proliferation through signaling pathways. This medication is also utilized for the treatment of metastatic gastric cancer characterized by elevated HER2 protein levels.
HER2-positive breast cancers are typically characterized by their aggressive nature. The targeted therapy for HER2-positive breast cancer functions by selectively inhibiting the proteins that govern cancer growth, development, and dissemination. The use of effective contraception is mandatory during treatment and for a minimum of 7 months following the cessation of therapy.
Hertrust 150mg Injection is contraindicated in patients under 18 years of age, and in those with severe respiratory compromise or requiring supplemental oxygen. It is imperative to disclose any history of cardiac conditions, dyspnea, or prior oncological treatments to your physician. Patients must inform their physician of all concomitant medications, including dietary supplements and herbal remedies, prior to commencing Hertrust treatment.
Option 4: Concise Summary
Hertrust 150mg Injection, containing Trastuzumab, treats HER2-positive breast cancer and metastatic gastric cancer with high HER2 levels. It targets the HER2 proteins that fuel aggressive cancer growth. Effective birth control is required during and for 7 months after treatment. Hertrust is not for patients under 18, those with severe breathing problems, or on oxygen. Inform your doctor about heart issues, breathlessness, past cancer treatments, and all current medications, including supplements and herbal remedies

The Hertrust 150mg Injection is used in the treatment of the following:

Advanced and metastatic breast cancer
Metastatic gastric cancer

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Hertrust 150mg Injection selectively binds to HER2 and stops the growth of cancer cells.

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Hertrust 150mg Injection and cause undesirable side effects.

Keep Hertrust 150mg Injection out of sight and reach of children. Store between 2˚C and 8˚C